Synergistic action between a synthetic cannabinoid compound and tramadol in neuropathic pain rats
In the present study the interaction of cannabinoid, PhAR-DBH-Me [(R, Z)-18-((1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-18-oxooctadec-9-en-7-ylphenyl-acetate] and tramadol in two neuropathy models, as well as their possible toxic effects, was analyzed. The anti-allodynic effect of PhAR-DBH...
Saved in:
Main Authors: | Quiñonez-Bastidas Geovanna Nallely, Osuna-Martínez Ulises, Reda-Licea Ana Laura, López-Ortíz Manuel, Regla Ignacio, Navarrete Andrés |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2022-0037 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tramadol use and incident dementia in older adults with musculoskeletal pain: a population-based retrospective cohort study
by: Si Nae Oh, et al.
Published: (2024-10-01) -
Abuse and misuse of tramadol in patients with non-oncologic pain in a region of Southern Europe
by: M. Perelló, et al.
Published: (2025-12-01) -
Impact of Exercise on Tramadol-Conditioned Place Preference
by: Haneen Amawi, et al.
Published: (2025-01-01) -
Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use – a review
by: Helena M. Teixeira, et al.
Published: (2025-01-01) -
Cannabinoids and the endocannabinoid system in liver diseases
by: Anna Parfieniuk-Kowerda, et al.
Published: (2024-12-01)